This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tigchelaar, I. Articles by van Oeveren, W. Search for Related Content PubMed PubMed Citation Articles by Tigchelaar, I. Articles by van Oeveren, W. Pubmed/NCBI databases Substance via MeSH Hazardous Substances DB GELATIN Medline Plus Health Information Heart Surgery Social Bookmarking                         What's this?

Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients

Blood Interaction Research, Cardiothoracic Surgery, University Hospital Groningen, Groningen

Rolf CG Gallandat Huet

Department of Anaesthesiology, University Hospital Groningen, Groningen

Piet W Boonstra

Department of Cardiothoracic Surgery, University Hospital Groningen, Groningen

Willem van Oeveren

Blood Interaction Research, Cardiothoracic Surgery, University Hospital Groningen, Groningen

Ten per cent low molecular weight hydroxyethyl starch is a plasma substitute only recently used as priming solution in an extracorporeal circuit, in contrast to human albumin and gelatin. To evaluate the effect of priming solutions on haemodynamics and colloid osmotic pressure, we studied 36 patients elected for cardiopulmonary bypass (CPB). They were randomly assigned to 2.5% hydroxyethyl starch, 3% gelatin or 4% human albumin priming solution.

Total blood loss (perioperative + intensive care unit period) was higher in the gelatin group than in the albumin and hydroxyethyl starch groups. During CPB, the colloid osmotic pressure was best preserved in the gelatin group, although no excessively low colloid osmotic pressures were measured in the other two groups. Due to the extended half-life and the additional postoperative colloid administration, the hydroxyethyl starch group had a higher colloid osmotic pressure in the postoperative phase.

We conclude that, next to human albumin, 2.5% hydroxyethyl starch is a safe CPB priming solution additive and is effective as plasma substitute. Its somewhat longer half-life requires adaptation of the routine protocol for transfusion of colloids and blood products.

Perfusion, Vol. 13, No. 5, 297-303 (1998)
DOI: 10.1177/026765919801300503


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. J. Gu and P. W. Boonstra Selection of priming solutions for cardiopulmonary bypass in adults MMCTS, January 9, 2006; 2006(0109): 1198. [Abstract] [Full Text] [PDF]

				Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1247 - 1259. [Full Text] [PDF]

				M. E. Barron, M. M. Wilkes, and R. J. Navickis A Systematic Review of the Comparative Safety of Colloids Arch Surg, May 1, 2004; 139(5): 552 - 563. [Abstract] [Full Text] [PDF]

				J. Avorn, M. Patel, R. Levin, and W. C. Winkelmayer Hetastarch and Bleeding Complications After Coronary Artery Surgery Chest, October 1, 2003; 124(4): 1437 - 1442. [Abstract] [Full Text] [PDF]

				M. M. Wilkes, R. J. Navickis, and W. J. Sibbald Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding Ann. Thorac. Surg., August 1, 2001; 72(2): 527 - 533. [Abstract] [Full Text] [PDF]